- Clone
- A22018C (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Receptor tyrosine-protein kinase erbB-2 (ERBB2), human epidermal growth factor receptor 2 (HER2), metastatic lymph node gene 19 protein (MLN19), Proto-oncogene Neu, p185erbB2, cluster of differentiation 340 (CD340), NGL, VSCN2, TKR1
- Isotype
- Mouse IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
619451 | 25 µg | 170 CHF | ||||
619452 | 100 µg | 425 CHF |
CD340, also commonly known as ErbB2 or HER2, is a member of the epidermal growth factor receptor family of cell membrane tyrosine kinases containing a single transmembrane domain. CD340 contains three furin repeats and two cheY homologous receiver domains in the extracellular region. Although CD340 itself contains no ligand binding domain, it interacts with other EGF receptor family members to form a heterodimer, stabilize ligand binding, and enhance kinase-mediated downstream signaling. CD340 is involved in embryonic development and cancer progression; this protein is amplified in adenocarcinoma of the lung, some breast cancers, glioblastoma, gastric cancer, and ovarian carcinoma, where it functions as an oncogene. Overexpression of CD340 in breast cancers has been shown to confer Taxol resistance, and CD340 is a therapeutic target in a number of human cancers. CD340 activation is accompanied by autophosphorylation at multiple tyrosine residues including Tyr1248.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Synthetic human CD340 peptide phosphorylated at Tyr1248
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
WB - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by western blotting. For western blotting, the suggested use of this reagent is 0.25 - 1.0 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
-
A22018C is not suitable for ICC or ICFC
- RRID
-
AB_3068143 (BioLegend Cat. No. 619451)
AB_3068143 (BioLegend Cat. No. 619452)
Antigen Details
- Structure
- CD340 is a 1,255 amino acid protein with a predicted molecular weight of 137.9 kD.
- Distribution
-
Plasma membrane, cytoplasm, nucleus
- Function
- Proto-oncogene, protein tyrosine kinase receptor
- Interaction
- CD340 interacts with a large number of proteins, including SHC1, EGF receptor, neuroregulin 1, c-Src, integrin β4, Grb2, Grb7, SOS1, caveolin 1, JAK2, PAK1, FAK, and β-catenin, among others.
- Cell Type
- Leukemia
- Biology Area
- Cell Biology, Immunology, Neuroscience, Synaptic Biology
- Molecular Family
- Adhesion Molecules, CD Molecules, Phospho-Proteins
- Antigen References
-
- Akiyama T, et al. 1986. Science. 232:1644-6.
- Bargmann CI, et al. 1986. Nature. 319:226-30.
- Pegram MD, et al. 1997. Oncogene. 15:537-47.
- Slamon DJ, et al. 1989. Science. 244:707-12.
- Leone F, et al. 2003. J Leukoc Biol. 74:593-601.
- Gene ID
- 2064 View all products for this Gene ID
- UniProt
- View information about CD340 on UniProt.org
Related FAQs
Other Formats
View All CD340 Phospho Tyr1248 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-CD340 (erbB2/HER-2) Phospho (Tyr1248) | A22018C | WB |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Purified anti-CD340 (erbB2/HER-2) Phospho (Tyr1248)
Whole cell extracts (15 µg total protein) from MCF-7 cells u...
Follow Us